INTRODUCTION
The recent introduction of reduced intensity conditioning (RIC) regimens has modified allogeneic hematopoietic cell (HC) transplantation. While shifting away from toxic myeloablative conditioning regimens, such an approach can result in increased graft failure ( ). In addition, reduced intensity conditioning transplantation (RICT) might be associated with less frequent incidence, less severe 1 clinical form and/or delayed onset of acute graft-versus-host disease (GVHD) than conventional myeloablative allograft while a similar frequency of chronic graft-versus-host disease (cGVHD) has been reported ( ). Allogeneic RICT are associated with delayed 1 -4 conversion to full-donor chimerism with longer host HC persistence. In experimental murine models, this state of mixed chimerism observed after allogeneic RICT offers several advantages over full-donor chimerism, including immunological competence ( ), reciprocal 5 graft-host tolerance ( , ) and superior graft-versus-leukemia (GvL) effect ( ). All these advantages have been related to the presence of 5 6 7 both recipient and donor antigen-presenting cells (APC) ( ). Dendritic cells (DC) can be considered as the major APC involved in the 5 -7 control of allo-immune responses after BMT (as discussed in Ref. ) . Donor DC homing in the thymus may participate to negative 8 selection of alloreactive T cells together with host DC. In peripheral organs, host APC and notably DC seems to be critical to initiate acute GVHD ( , ) and to favor GvL effect ( ). However, other immunologically active host HC subsets than DC persist and may 9 10 7 -- influence the alloreactive interactions between donor and host immune cells. Here, we observed in a murine bone marrow transplantation (BMT) model that mixed chimeric mice presented higher levels of circulating pathogenic IgG auto-antibodies (Abs) than in non-or full-donor chimeric mice and preferentially developed cGVHD-like lesions. This increase of IgG auto-Abs in mixed chimeric mice was associated with an increase of total IgG levels. This suggests a polyclonal activation in these mixed chimeric recipients that can be related
Transplantation . Author manuscript Page / 2 13 to the alloreactive conflict observed after transplantation. The persistence of host B cells together with donor T cells was identified as a factor associated with cGVHD occurrence. The involvement of host B cells in mixed chimeric mice was confirmed by the recipient origin of circulating auto-Abs. Such observation might be clinically relevant and contribute to cGVHD occurrence and/or severity after allogeneic RICT.
MATERIALS AND METHODS

Bone marrow transplantation
Pathogen-free male (5 6 weeks) BALB/c mice (Janvier, Le Genest-St-Isle, France) received a limited number of bone marrow (BM) -cells (10 ) from FVB donors following a sub-lethal 6 Gy total body irradiation. Experiments were performed according to institutional 6 guidelines. All mice described in this study corresponded initially to control recipients used to evaluate novel cell-based therapy approaches favoring HC engraftment. The initial observation consisting of a retrospective analysis involving six independent experiments -was done by chance when some of these control receiving only a limited number of BM cells developed late GVHD-like lesions (> 45 -days). These lesions were identical to those encountered in the chronic form of GVHD, as attested by pathological examination. Then, three prospective experiments were performed to further explore cellular factors involved in the occurrence of cGVHD in mixed chimeric mice.
Chimerism analysis
Engraftment was evaluated on either splenocytes or thymocytes at time of sacrifice or on peripheral blood mononuclear cells (kinetic studies) by flow cytometry using specific anti-H2 monoclonal Abs (mAbs), as previously reported ( ). Recipients were considered 11
full-donor chimeric when > 98 of cells exhibited donor phenotype, non-chimeric in the absence (< 2 ) of donor cells, and mixed in all 
Auto-antibody detection
Anti-double stranded (ds) DNA and anti-cardiolipin (AcL) auto-Abs were assessed by ELISA, as described ( 
Pathological examination and immunohistochemical staining
All grafted mice involved in this study were prospectively followed for the development of clinical signs of GVHD according to the scoring system initially proposed by Ferrara s group ( ). All mice developing clinical signs of GVHD and in particular abnormality in fur ' 
15
texture (severe ruffling) or in skin integrity (areas of denuded skin) were sacrificed and pathological examination of the skin, kidney, liver and gastro-intestinal tract was performed. Healthy mice grafted the same day as mice developing GVHD-like lesions were randomly selected and analyzed for chimerism and by a pathologist blinded to the nature of the mice being examined. 
RESULTS
Mixed chimeric recipients exhibit higher levels of circulating IgG auto-antibodies after allogeneic BMT than full-donor-or non-chimeric mice
In experimental conditions designed to limit donor engraftment, 284 BM recipients from 9 independent experiments were analyzed for splenic engraftment 7 9 week post-BMT. Among these mice, 58.4 (166/284) had rejected their graft, whereas 9.9 (28/284) presented were found in mixed chimeric mice (anti-dsDNA auto-Abs: 192 U/mL 1-1716 (median range ), n 52 AcL auto-Abs: 834 U/mL 17-7466
, n 70) than in non-chimeric (anti-dsDNA Abs: 75 U/mL 2-825 , n 108, <.01; AcL Auto-Abs: 111 U/mL 10-4398 , n 117, <.01) or
full-donor chimeric mice (anti-dsDNA Abs: 73 U/mL 2-266 , n 19, <.01; AcL auto-Abs: 164 U/mL 3-831 , n 24, <.01,
No statistical difference was observed between auto-Ab levels found in full-donor-or in non-chimeric mice ( .91 for anti-dsDNA and .57 for AcL auto-Abs, Mann-Whitney Rank Sum Test). The high median auto-Ab levels observed in P = P = mixed chimeric mice resulted from the presence of high levels (> to the mean 2 SD of Ab levels in naive mice) of auto-immune IgGs in 9/117) ( <.01 between mixed chimeric mice and other groups, except for AcL auto-Abs between mixed-and full-donor chimeric mice P where .07; Mann-Whitney Rank Sum Test, ). P = Figure 1B 
Self-immunization is preferentially observed in mixed chimeric recipients
An isotype switch from natural IgM auto-Abs that react weakly with self-antigens (Ags) to high affinity pathogenic IgG is observed
. Kinetics of IgM and IgG auto-Ab production after BMT were analyzed in 8 randomly selected 17 18 mice from each group (non-chimeric, full-donor and mixed chimeric mice). In a majority of mice (20/24), low levels of both anti-dsDNA and AcL IgGs (< 151 U/mL) were detected, as observed in age-matched naive mice ( ). In these mice, natural IgM auto-Ab Figure 1C serum concentration reached the levels found in age-matched naive mice 2 4 week post-BMT, therefore suggesting the absence of ). In contrast, a decrease of both anti-dsDNA and AcL auto-Ab IgM levels simultaneously to an increase of Figure 1C auto-Ab IgG levels was observed in 4 mixed chimeric mice out of 8 analyzed (
). This suggested a self-immunization in these 4 Figure 1C mixed chimeric mice.
Mixed chimeric recipients exhibit higher levels of total circulating IgGs than full-donor-or non-chimeric mice
Total IgG Ab titers were measured 7 9 weeks post-BMT in the 3 different groups of recipients. Significant higher levels of total IgGs -were detected in mixed chimeric mice (0.59 g/L 0.21 0.77 (median range ), n 10) than in non-chimeric (0. 30 g/L 0.09 0.72 ), n 6, Figure 2A observed between non-and full-donor chimeric recipients ( .4, Mann-Whitney Rank Sum Test). Only mixed chimeric mice exhibited P = significant higher levels of total IgGs than naive BALB/c mice (0.11 g/L 0.07 0.12 , n 6, <.01, Student test). Altogether, increase of full-donor and mixed chimeric mice) were sacrificed 7 9 months post-BMT and examined for pathology. Chronic GVHD-like lesions ( -) were exclusively found in 13 out of 21 mixed chimeric recipients tested, whereas no lesions were observed in 13 full-donor- Figure 3A -B ( <.01; Mann-Whitney Rank Sum Test) or 37 non-chimeric mice ( <.01, Mann-Whitney Rank Sum Test). Furthermore higher levels of P P
IgG auto-Abs (anti-dsDNA Abs: 25-1599 U/mL, median: 931; AcL Abs: 136-4078 U/mL, median: 779) were found in these 13 mixed chimeric recipients developing cGVHD-like lesions when compared to healthy mixed chimeric mice ( <.01 for anti-dsDNA). This P strongly suggests a correlation between mixed chimeric state, high levels of IgG auto-Abs and cGVHD-like lesion occurrence.
Chronic GVHD-like lesions are preferentially found in mixed chimeric recipients demonstrating a divergent T and B chimerism with mostly donor T cells and host B cells
To further explore cellular factors explaining the occurrence of cGVHD in mixed chimeric mice, we also analyzed the presence of donor-derived cells in the thymus. Donor-derived cells in T lymphoid lineage were comparable in mixed chimeric mice developing or not developing cGVHD-like lesions ( ). Reciprocal graft-host tolerance is linked to co-existence of thymic host and donor CD11c DC Table 1 + participating to the negative selection ( , ). However, engraftment in thymic DC was similar whatever the considered mixed chimeric 5 20
mice (
). Because patients with cGVHD exhibited significantly higher plasmacytoid DC (pDC) numbers ( ), DC origin and Table 2 21
subsets (myeloid vs. pDC) were also analyzed in the spleen of these mice. Based on B220 expression, myeloid DC (CD11c B220 ) can be + − distinguished from pDC (CD11c B220 ) ( , ). The repartition of splenic DC subsets or origin was also not different in mice + + 22 23 developing cGVHD-like lesions or not ( ). Table 2 Host B-cell stimulation induced by alloreactive donor T cells is believed to induce and maintain cGVHD in a murine model involving parental T cell transfer (without BM) into unirradiated F1 mice ( ). We therefore determined B-cell chimerism in the peripheral blood 16 and compared it to T-cell chimerism, 9 weeks post-BMT. Among 134 recipients from 4 independent experiments, 36 were mixed chimeric mice ( ). Whereas similar B-and T-cell engraftment (in a given mouse) was found in 20 healthy mixed chimeric mice, the 16 Table 1 recipients developing cGVHD exhibited a divergent B-and T-cell chimerism with mostly host B cells (17. Table 1 in full-donor chimeric mice since all the cells were from donor origin ( and ). Chimerism analysis in mixed chimeric mice Figure 4 Table 1 was extended to T cell subsets. Comparable levels of donor chimerism were found in splenic CD4 T cells and in CD8 T cells from
healthy mixed chimeric mice and mixed chimeric mice developing cGvHD-like lesions ( ). However, CD4/CD8 imbalance was Table 1 detected in mice developing such lesions while healthy recipients exhibited a CD4/CD8 ratio higher than 1 (P<.05, ). Table 1 Type 1 (IFN-) and 2 (IL-13) cytokine profiles were also determined in 53 grafted mice (11 healthy mixed chimeric mice, 10 mixed 
DISCUSSION
graft-host tolerance appears prominent ( , , , ). Here, we show that about half of the mixed chimeric mice presented preferentially 5 6 24 25 higher levels of host-derived pathogenic IgG auto-Abs than full-donor or non-chimeric mice and that such mice developed subsequently cGVHD-like lesions. Healthy mixed chimeric mice could be distinguished from those developing cGVHD-like lesions on the basis of Band T-cell chimerism. Indeed, mixed chimeric mice presenting cGVHD-like lesions exhibited a divergent B-and T-chimerism with mostly host B cells and donor T cells while healthy chimeric mice showed similar engraftment in B and T cell populations. In addition, mixed chimeric mice developing cGVHD-like lesions presented a CD4/CD8 imbalance. In this experimental model, we did not correlate the occurrence of such cGVHD-like lesions with a particular distribution of DC subset or origin. Altogether, these results show that mixed chimeric state is not always advantageous and suggest that such a state is not constantly associated with tolerance.
Chronic GVHD is an alloimmune disease associated with autoimmune features ( ) and is closely related to systemic autoimmune 26 disease in mice ( ). As such, cGVHD may result from the occurrence of multiple factors ( , ). Whereas some differences exists (for  16  26 We could not correlate a cGVHD episode with a particular distribution of DC subset or origin. All mixed chimeric mice whatever their status (healthy or none) exhibited host as well as donor splenic myeloid and pDC (
). This suggests that such cells do not influence Table 2 cGVHD occurrence in our model. Nevertheless, autoreactive B cell activation may occur independently of DC in response to alloreactive donor T cell stimulation ( ). Activated host B cells may be potent APC for indirect allorecognition ( ). This may contribute to 16 37 alloreactive donor T cell activation creating therefore an amplification loop.
There are some discrepancies with the studies reporting reciprocal host-graft tolerance in a murine model ( , ). There main 24 25 differences between this ( , ) and our model include: recipient strain (BALB/c mice in our study which are prone to autoimmune 24 25 
vs. 837 284 2638 CD3 cells/ l, n 6 mice/group). In addition, these mice developing cGVHD showed evidence of a CD4/CD8
imbalance. However, it was difficult to ascertain whether such altered immune reconstitution was due to GVHD or was responsible for GVHD, as GVHD may lead to lymphopenia ( ). 16
The relation between mixed chimerism, persistence of host B cells and cGVHD after RICT in humans is presently difficult to assess.
Detailed clinical and chimerism data is scarce. In addition, several confounding factors such as the type of RIC regimen (i.e., with or without anti-lymphocyte globulin, affecting B cells or not), the presence or absence of acute GVHD or the use of donor lymphocyte infusions in the presence of mixed chimerism render data interpretation difficult. However, on the basis of a study involving 12 patients, full donor B-cell chimerism was delayed when compared to full donor T-cell chimerism ( ). Moreover, although B cell chimerism was 44 not directly addressed, cGVHD occurrence in 2 patients with persisting mixed lymphoid chimerism was reported ( ). Although a study 45 involving a myeloablative conditioning regimen failed to find an association between circulating auto-Abs and cGVHD ( ), auto-Abs, 46
including lupus anticoagulant and AcL Abs, have been described in patients developing cGVHD ( , ). Finally, a recent interesting 47 48 clinical report shows that host-derived Abs persist much longer in the setting of RICT than after myeloablative allografts ( ). These 49 authors reported recently that this was due to the persistence of host plasma cells that resist to RIC regimen associating cyclophosphamide and fludarabine ( ). In the 12 patients analyzed, host plasma cells detected in the bone marrow persisted whereas all T cells were from 50 donor origin. Disappearance of recipient plasma cells was correlated with decrease of anti-donor Ab titers ( ). Overall, our results 50
suggest that mixed chimerism after RICT could be associated with recipient B cell persistence, increased auto-immunity and cGVHD.
Such a novel association could be clinically highly relevant and could suggest that mixed chimerism is not always associated with bi-directional tolerance. In addition, B-cell chimerism monitoring may contribute to cGVHD prevention by anticipating appropriate immunosuppression.
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We Significant higher levels of circulating total IgGs correlated with higher levels of IgG auto-Abs are preferentially found in mixed chimeric mice ( ) Circulating total IgGs ( g/l) 9 weeks post-BMT were significantly higher in mixed chimeric mice (MCM; n 10) than in non-(NCM; n A μ = = 6) or in full-donor chimeric mice (FDCM; n 10). [ -] n = 98 88 100 ( 10)
[ -] n = Results from 2 4 independent experiments are expressed as median range of donor derived cells, except for CD4/CD8 ratio that represent the percentageof CD4 T cells divided by the percentage of
CD8 T cells whatever their origin. Representative cytometric profiles for B and T chimerism were shown . Staining was performed on fresh cells, except in three mice per group for which Figure 4 CD3/CD4/CD8/H-2q staining was performed on frozen spleen cells. Chimericstate is defined by cytometry on lymphoid spleen cells; thymocytes represent double positive thymocytes as well as single positive thymocytes. * The difference in the values between healthy MCM and cGVHD MCM groups is statistically significant (P < 0.05, Student t test).
NCM, nonchimeric mice; MCM, mixed chimeric mice; FDCM, full donor chimeric mice. 
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